Urapidil, compared to nitroglycerin, has better clinical safety in the treatment of hypertensive patients with acute heart failure: a meta-analysis

Urapidil, compared to nitroglycerin, has better clinical safety in the treatment of hypertensive patients with acute heart failure: a meta-analysis

Jiaxiao Shi,1,2,* Yulin Li,1,2,* Cong Xing,1,2,* Peng Peng,1,2 Hongyu Shi,1,2 Han Ding,1,2 Pengyuan Zheng,1,2 Guangzhi Ning,1,2 Shiqing Feng1,2 1Department of Orthopaedics, Tianjin Medical University General Hospital, Heping District, Tianjin 300052, PR China; 2Tianjin Neurological Institute, Key L...

Full description

Bibliographic Details
Main Authors: Shi J, Li Y, Xing C, Peng P, Shi H, Ding H, Zheng P, Ning G, Feng S
Format: Article
Language:English
Published: Dove Medical Press 2018-12-01
Series:Drug Design, Development and Therapy
Subjects:
Urapidil
nitroglycerin
acute heart failure
meta-analysis
Online Access:https://www.dovepress.com/urapidil-compared-to-nitroglycerin-has-better-clinical-safety-in-the-t-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/urapidil-compared-to-nitroglycerin-has-better-clinical-safety-in-the-t-peer-reviewed-article-DDDT

Similar Items